IBA and Philips partner to create patient-centric proton therapy
19 May 2011
IBA Group and Philips have entered into an agreement to create
patient-centric proton therapy centres.
The design of the centres focuses on the emotional and physical
aspects of patient care. From the moment they enter the center up to
their final treatment, the patient is surrounded by light, image and
sound, making the treatment experience as soothing and transparent
as possible, while helping caregivers to work more efficiently.
IBA and Philips presented their plans together at the European
Society of Therapeutic Radiology and Oncology (ESTRO) Anniversary
Congress in London, UK, and the Particle Therapy Co-Operative Group
(PTCOG) conference in Philadelphia, Penn., USA, both last week.
The IBA-Philips ‘turnkey’ proton center concept is the first of
its kind, and is initially being developed for the Middle East
market, with subsequent plans to expand its use globally. Named
‘Proteus TK2’, the IBA-Philips center design encompasses all
elements necessary to build a complete proton therapy center.
This includes the building exterior and interior architecture,
two IBA proton therapy treatment rooms, Philips Ambient Experience
Design solutions, Philips CT, CT SIM, MRI imaging solutions and
patient monitoring equipment.
“This joint approach combines the strength of both companies that
believe in a true people-focused solution, which makes this concept
extremely attractive for those wanting to add proton therapy to
their cancer fighting therapies” says Pierre Mottet, Chief Executive
Officer of IBA.
Dr Eric Silfen, Chief Medical Officer, Philips Healthcare adds:
“We are very proud to work together with IBA Group, a global leader
in the proton technology market. Philips is committed to simplifying
oncology care for a patient group that is still growing around the